Insights
Practice Area
Emerging Companies
Overview
For over 40 years, we have helped founders, start-ups, and emerging companies form, finance, and grow their businesses, and have assisted countless angel investors and venture capital firms with their investment activities. We have decades of experience, and a high volume of formation, general corporate, and transactional work. With offices in Raleigh and in Durham’s American Tobacco Campus, and attorneys with outstanding commitment, our Emerging Companies practice group delivers responsive, high-value services to clients located throughout the United States (including entrepreneurial hotspots such as Silicon Valley, New York, Boston, Austin, and elsewhere).
We regularly act as outside general counsel for founder and company clients, assisting with a wide variety of matters such as:
- entity choice and organization;
- stockholder agreements;
- board and stockholder management;
- capital raising and securities law compliance;
- commercial contracts and strategic relationships;
- licensing, trademarks, and other intellectual property;
- employment, consultant, and adviser matters;
- benefits and equity incentive programs; and
- mergers and acquisitions.
Our clients include, among many others, serial and first-time entrepreneurs, university professors, garage tinkerers, moonlighting programmers, bench scientists, established start-ups, growth companies, angel investors, and a variety of venture capital and private equity funds.
Our team has a scale and depth that allows us to innovate and streamline routine processes and to participate broadly in the start-up and emerging growth community. We also help organize and sponsor local and regional events, sit on boards of nonprofit and other organizations, speak on panels, provide pro bono advice at incubators and accelerators, and author articles and other reference materials in our industry.
To discuss our Emerging Companies expertise and services, please contact Tom Allen at 919.865.1117 or tallen@wyrick.com.
Meet Our Team
Responsive, committed, client-centric relationships. We believe great people attract great clients and great clients attract great people.
View Full Team
Select Transactions
Feb 2023
Series A-1 Preferred Stock Financing
$20,000,000
Jan 2023
Loan and Security Agreement
$2,500,000
Dec 2022
Lead Investor In
Series B Preferred Stock Financing
$25,000,000
Nov 2022
Convertible Note Financing
Nov 2022
Series B Preferred Stock Financing
Oct 2022
Series C Preferred Units Financing
$110,000,000
Oct 2022
Joint Marketing and Artist Social Media Strategic Partnership with Fuzzy Endorsements LLC for
Sep 2022
Convertible Note Financing
$2,500,000
Aug 2022
Series Seed-2 Preferred Stock Financing
$4,000,000
Jul 2022
Convertible Promissory Note Financing of
Jun 2022
Series Seed Preferred Stock Financing
$1,000,000
Jun 2022
Sale of Common Stock
$29,000,000
These securities have been
previously sold. This announcement
appears as a matter of record only.
May 2022
Co-Lead Investor In
Series C Preferred Stock Financing
$35,000,000
May 2022
Series B Preferred Stock Financing
$40,000,000
Apr 2022
Series A Preferred Stock Financing
$11,500,000
Mar 2022
Series A Preferred Stock Financing
$3,000,000
Jan 2022
Series B Preferred Stock Financing
$27,000,000
Jan 2022
Series B-2 Preferred Stock and Warrants Financing
$6,000,000
Dec 2021
Class A Unit Financing
$1,500,000
Nov 2021
Series Seed Preferred
Stock Financing
$3,697,000
Oct 2021
Series Seed Preferred Stock Financing
$2,387,965.06
Sep 2021
Series D Preferred Unit Financing
$116,000,000
Aug 2021
Series A Preferred Stock Financing
$10,300,000
Jun 2021
Series A Preferred Stock Financing of
Jun 2021
Series D Preferred Stock Financing
$13,700,000
Jun 2021
Series D Preferred Stock Financing
$18,000,000
May 2021
Series C Preferred Stock Financing
Apr 2021
Series A Preferred Stock Financing of
Apr 2021
Series A Preferred
Stock Financing
$12,600,000
Jan 2021
Convertible Note Financing
Jan 2021
Series B Preferred Stock Financing
$2,350,000
Dec 2020
completed a merger with
and closed a
$37,000,000
Preferred Stock financing
Jul 2020
Series Seed Preferred Stock Financing of
May 2020
Series 1 Preferred Stock Financing of
$8,000,000
Apr 2020
Series Seed
Financing
$1,250,000
Mar 2020
Series C Financing
$11,635,896.05
Jan 2020
Series Seed Preferred
Stock Financing
$5,000,000
Dec 2019
Series C Preferred
Stock Financing
Dec 2019
SeriesC Preferred Stock Financing
for NoHo Health, Inc.
US$25,000,000
Nov 2019
Series B Investment
in eGenesis Bio
US$50,000,000
Jul 2019
Class A Preferred Unit Financing
Approximately $13,000,000
Jul 2019
$3,500,000
Class A Preferred Units
Jun 2018
Series A Financing
Up to $6 Million
Mar 2018
Series A Financing
$4,600,000
Feb 2018
Series A Financing
$4,500,000
Aug 2017
Series B Financing
$10,000,000
Aug 2017
Series B Preferred Stock Financing
$5,000,000
Jun 2017
Seed Financing
$4,600,000
May 2017
Series B Preferred Stock Financing
$2,200,000
May 2017
Convertible Promissory Note
Financing of
StrideBio, Inc.
Apr 2017
Class A Unit Financing
$2,500,000
Mar 2017
Series A Preferred
Stock Financing of
Boragen, Inc.
$10,000,000
Jan 2017
Series Seed Preferred Stock
Financing
$2,150,000
Dec 2016
Series B Preferred Stock
Financing
$20,000,000
Nov 2016
has been selected by
the State of North Carolina
as the manager for the
$60,000,000
Venture Capital Multiplier Fund
Sep 2016
Series A Preferred Stock
Financing
$14,200,000
Aug 2016
Formation of
$10,000,000
Venture Capital Fund
Aug 2016
Series C Preferred Stock Financing
$6,200,000
Aug 2016
Class A Unit Financing
$2,100,000
May 2016
Series A Preferred Stock Financing
$2,000,000
Oct 2015
Series A Preferred Stock
Financing
$11,000,000
Aug 2015
Series B Preferred Stock
Financing
$14,285,000
Aug 2014
Series E Preferred Stock
Financing
Jul 2014
Series A Preferred Stock
Financing
$11,000,000
Dec 2012
Series A Preferred Stock
Financing
Aug 2012
Series 1 Preferred Stock
Financing of
Jun 2012
$5,495,237
Series B Preferred Stock
Financing of
Jun 2012
$3,600,000
Series C Preferred Stock
Financing
Mar 2012
Series A Financing of
Nov 2011
$4,500,000
Series A Preferred Stock
Financing of
Nov 2011
$13,900,000
Series B Preferred Stock
Financing of
Aug 2011
$13,155,000
Series D Preferred Stock
Financing
Jun 2011
$5,000,000
Series C Preferred Stock
Financing of
Jun 2011
$35,000,000
Series D Preferred Stock
Financing
Apr 2011
$3,000,000
Series A Preferred Stock
Financing of
Row Sham Bow, Inc.
Feb 2011
has formed
Anchor Capital Fund VI, L.P.
